Case Report: Deep Brain Stimulation to the Ventral Internal Capsule/Ventral Striatum Induces Repeated Transient Episodes of Voltage-Dependent Tourette-Like Behaviors.

DBS MDD PET Tourette syndrome brain stimulation neuromodulation

Journal

Frontiers in human neuroscience
ISSN: 1662-5161
Titre abrégé: Front Hum Neurosci
Pays: Switzerland
ID NLM: 101477954

Informations de publication

Date de publication:
2020
Historique:
received: 01 08 2020
accepted: 15 12 2020
entrez: 11 2 2021
pubmed: 12 2 2021
medline: 12 2 2021
Statut: epublish

Résumé

Deep Brain Stimulation (DBS) is an invasive device-based neuromodulation technique that allows the therapeutic direct stimulation of subcortical and deep cortical structures following the surgical placement of stimulating electrodes. DBS is approved by the U.S. Federal Drug Administration for the treatment of movement disorders and obsessive-compulsive disorder, while new indications, including Major Depressive Disorder (MDD), are in experimental development. We report the case of a patient with MDD who received DBS to the ventral internal capsule and ventral striatum bilaterally and presented with 2 weeks of voltage-dependent Tourette-like symptoms including brief transient episodes of abrupt-onset and progressively louder coprolalia and stuttered speech; tic-like motor behavior in his right arm and leg; rushes of anxiety, angry prosody, angry affect; and moderate amnesia without confusion. We describe the results of the inpatient neuropsychiatric workup leading to the diagnosis of iatrogenic voltage-dependent activation of cortico-subcortical circuits and discuss insights into the pathophysiology of Tourette as well as safety considerations raised by the case.

Identifiants

pubmed: 33568978
doi: 10.3389/fnhum.2020.590379
pmc: PMC7869408
doi:

Types de publication

Journal Article

Langues

eng

Pagination

590379

Informations de copyright

Copyright © 2021 Camprodon, Chou, Testo, Deckersbach, Scharf and Dougherty.

Déclaration de conflit d'intérêts

DDD has received honoraria, consultation fees and/or royalties from Medtronic, Wyeth, Jazz Pharmaceuticals, Bristol Myers Squibb, Brand Ideas, and Reed Elsevier. The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

J Neural Transm (Vienna). 2016 Jul;123(7):791-796
pubmed: 27209036
J Neuropsychiatry Clin Neurosci. 2016 Winter;28(1):38-44
pubmed: 26404172
Am J Psychiatry. 2006 Jan;163(1):159
pubmed: 16390908
Neuroimage. 2003 Jul;19(3):1233-9
pubmed: 12880848
J Neurol Sci. 2020 Feb 15;409:116634
pubmed: 31864073
Epilepsy Behav. 2016 Jul;60:99-106
pubmed: 27195785
Front Neurol. 2016 Nov 10;7:193
pubmed: 27891112
Epilepsia. 2000 Jul;41(7):862-7
pubmed: 10897158
Pediatr Neurol. 2016 Apr;57:88-90
pubmed: 26880529
Nat Rev Dis Primers. 2017 Feb 02;3:16097
pubmed: 28150698
Biol Psychiatry. 2009 Feb 15;65(4):267-75
pubmed: 18842257
J Neurophysiol. 2016 Jan 1;115(1):19-38
pubmed: 26510756
J Clin Neurosci. 2019 Apr;62:269-272
pubmed: 30612913

Auteurs

Joan A Camprodon (JA)

Department of Psychiatry, Harvard Medical School, Boston, MA, United States.
Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States.

Tina Chou (T)

Department of Psychiatry, Harvard Medical School, Boston, MA, United States.

Abigail A Testo (AA)

Department of Psychiatry, Harvard Medical School, Boston, MA, United States.

Thilo Deckersbach (T)

Department of Psychiatry, Harvard Medical School, Boston, MA, United States.

Jeremiah M Scharf (JM)

Department of Psychiatry, Harvard Medical School, Boston, MA, United States.
Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States.

Darin D Dougherty (DD)

Department of Psychiatry, Harvard Medical School, Boston, MA, United States.

Classifications MeSH